Evidence-based Medicine and HMOs: Where Are We Now? Where Are We Going? Hania Szajewska

Allergy

Gut Microbiota

Growth & Development

Low Birth Weight

21.03.2019

A number of benefits of breastfeeding, particularly protection against child infections, may be, at least partially, related to the presence of human milk oligosaccharides (HMOs). Progress in biotechnology nowadays allows the production of at least some HMOs. Two HMOs, 2-fucosyllactose (2’-FL) and lacto-N-neo-tetraose (LNnT), have recently been added to infant formula, either alone or in combination. Professor Hania Szajewska presents the results of the clinical studies done with HMO-supplemented formulas to healthy infants, which shows some favorable clinical effects and no safety concerns with regard to growth and adverse effects.

Author(s): Hania Szajewska

Hania Szajewska

Presented at

6th International Conference on Nutrition & Growth (N&G 2019)

If you liked this post you may also like

Please log in to your profile so we can show recommended content.